Fund HoldingsAquilo Capital Management, LLC

Total Portfolio Value
$110.35M
Total Bought
$11.91M
Total Sold
$67.51M
Net Transaction
-$55.60M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
SILENCE THERAPEUTICS PLC1,312,2331,312,23307,21712,88611.68%+5,669
C4 THERAPEUTICS INC760,6571,990,334+1,229,6772,0923,7023.35%+1,610
PIERIS PHARMACEUTICALS INC3,303,1903,303,19005479840.89%+438
OLEMA PHARMACEUTICALS INC(OLMA)250,00088,875-161,1252,2581,0980.99%-1,160
REGENXBIO INC870,114847,424-22,69017,39413,94912.64%-3,445
KYMERA THERAPEUTICS INC(KYMR)651,325782,219+130,89414,97410,8739.85%-4,101
ARGENX SE(ARGX)16,3153,715-12,6006,3581,8261.66%-4,532
GENMAB A/S(GMAB)174,64852,148-122,5006,6381,8391.67%-4,799
ARVINAS INC623,941489,153-134,78815,4869,6078.71%-5,879
ARROWHEAD PHARMACEUTICALS IN(ARWR)858,474908,474+50,00030,61324,41122.12%-6,202
BLUEPRINT MEDICINES CORP448,987379,090-69,89728,37619,03817.25%-9,338
MERUS N V775,109430,109-345,00020,40910,1429.19%-10,267
ISHARES RUSSELL 2000 ETF TR(Put)150,0000-150,00028,0910-28,090
Page 1 of 1